H

Healius Ltd
ASX:HLS

Watchlist Manager
Healius Ltd
ASX:HLS
Watchlist
Price: 1.37 AUD -1.79% Market Closed
Market Cap: 994.8m AUD
Have any thoughts about
Healius Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one HLS stock under the Base Case scenario is 4.56 AUD. Compared to the current market price of 1.37 AUD, Healius Ltd is Undervalued by 70%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HLS Relative Value
Base Case
4.56 AUD
Undervaluation 70%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

0.6
P/S
P/S
Price to Sales
0.6
vs History
84
vs Industry
75
Median 3Y
0.9
Median 5Y
1.1
Industry
2.3
Forward
0.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
18
Median 3Y
5.4
Median 5Y
5.4
Industry
23.2
Forward
50.7
More Details
3.7
P/OCF
P/OCF
Price to OCF
3.7
vs History
60
vs Industry
49
Median 3Y
4
Median 5Y
4.6
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
39
Median 3Y
-3.7
Median 5Y
-3.7
Industry
20.1
More Details
1
P/B
P/B
Price to Book Value
1
vs History
41
vs Industry
63
Median 3Y
1.1
Median 5Y
1.1
Industry
2.2
More Details
1.3
EV/S
EV/S
Enterprise Value to Sales
1.3
vs History
84
vs Industry
60
Median 3Y
1.5
Median 5Y
1.8
Industry
2.4
Forward
1.3
More Details
1.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.5
vs History
85
vs Industry
73
Median 3Y
1.8
Median 5Y
2.1
Industry
5
More Details
34.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
34.5
vs History
14
vs Industry
9
Median 3Y
23
Median 5Y
23
Industry
12.8
Forward
6.9
More Details
34.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
34.5
vs History
14
vs Industry
13
Median 3Y
23
Median 5Y
23
Industry
17.2
Forward
36
More Details
8.5
EV/OCF
EV/OCF
Enterprise Value to OCF
8.5
vs History
22
vs Industry
40
Median 3Y
7.8
Median 5Y
7.9
Industry
14
More Details
11.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
11.2
vs History
15
vs Industry
32
Median 3Y
10.1
Median 5Y
10.1
Industry
18.2
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
53
vs Industry
64
Median 3Y
0.9
Median 5Y
0.9
Industry
1.9
More Details

Multiples Across Competitors

HLS Competitors Multiples
Healius Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Healius Ltd
ASX:HLS
994.8m AUD 0.6 -1.5 34.5 34.5
US
Cigna Group
XMUN:CGN
75B EUR 0.3 25.7 8 10.4
US
Cigna Corp
NYSE:CI
77.2B USD 0.3 25.4 8 10.3
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.9B EUR 1.3 39.2 10.7 23.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR 0.9 -49.3 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.2B USD 1.5 44.1 13.2 20.3
US
R1 RCM Inc
NASDAQ:RCM
17.7B USD 7.2 -289.7 38.3 99.1
US
Quest Diagnostics Inc
NYSE:DGX
16.9B USD 1.8 20.2 12.2 16.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 19.7 6.6 14.3
US
DaVita Inc
NYSE:DVA
12.4B USD 1 14.9 7.8 10.9
P/E Multiple
Earnings Growth PEG
AU
H
Healius Ltd
ASX:HLS
Average P/E: 25.1
Negative Multiple: -1.5 		N/A N/A
US
C
Cigna Group
XMUN:CGN
25.7
25%
1
US
Cigna Corp
NYSE:CI
25.4
25%
1
US
CVS Health Corp
NYSE:CVS
11.3
3%
3.8
DE
Fresenius Medical Care AG
XMUN:FME
39.2
31%
1.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.3 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.1
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -289.7
253%
N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.2
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
19.7
31%
0.6
US
DaVita Inc
NYSE:DVA
14.9
17%
0.9

See Also

Summary
HLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
HLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HLS stock valuation using valuation multiples.
Wall Street Estimates
HLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 212,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.